Biograil, a Copenhagen-based #BioTech company developing an #oral device to deliver therapeutics that would otherwise require injection, has closed a €20 millio...
Biograil, a Copenhagen-based #BioTech company developing an #oral device to deliver therapeutics that would otherwise require injection, has closed a €20 million #funding round. 🇩🇰💊 ❌ 💉
